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To the Editor: A previous report in 1999 by Bleyer on US SEER data suggested that decreases in the death rate from childhood cancer 16 
would cease completely by 2010 [1]. In response to this a corresponding analysis was conducted using data from England and Wales, for 17 
the same temporal period, and found that there was a similar decrease in deaths from childhood cancer from 8 to 3 per 100,000 children 18 
aged 0-14 years between 1958 and 1995. The authors speculated that there were two possibilities. Either deaths from childhood cancer 19 
would be completely eliminated by 2018 or would reach a point of no further improvement [2]. In order to see which, if any, of these 20 
predictions were correct we re-visited this important question by analysing recent temporal trends using up to date data on deaths in 21 
children. Cancer mortality data on children aged 0-14 years for the whole of England and Wales, who died during 1981-2014, were 22 
extracted from the Office for National Statistics [3]. Crude death rates per 100,000 children per year, together with 95% confidence 23 
intervals (CIs), were calculated, based on mid-year population estimates from the Office for National Statistics. Temporal trends in death 24 
rates were analysed using Poisson regression models that included time period as a covariate. The crude cancer mortality rates for all 25 
children have fallen from 5.11 (95% CI 4.67-5.55) per 100,000 children per year in 1981 to 2.32 (95% CI 2.03-2.62) in 2014. Rates for 26 
males and females in 1981 were respectively 5.48 (95% CI 4.84-6.12) and 4.73 (95% CI 4.12-5.33). In 2014 these rates had fallen 27 
respectively to 2.59 (95% CI 2.15-3.02) and 2.05 (95% CI 1.65-2.45). Analysing pooled data for both sexes using Poisson regression 28 
models with log of population as the offset, revealed that the trend was log-linear (Figure 1). Alternative models in which the log of the 29 
rate had trends that were cubic or quadratic were tried. However, the best fitting model was one with a linear downward trend. Parker and 30 
Craft had speculated that by 2018 either there could be zero deaths, no further reduction in mortality or something in between [2]. This 31 
updated analysis demonstrates that the latter scenario is what has happened. It is clear that there is a continued decrease in mortality 32 
3 
 
from childhood cancer and that this is likely to continue. The model predicts that the mortality rate will decrease exponentially, so that by 33 
2024 the death rate would be predicted to be 1.84 per 100,000 children per year and by 2034 it would be predicted to be 1.47 per 34 
100,000 children per year. Future efforts should concentrate on factors that may eventually lead to zero deaths. These could include 35 
improvements in therapeutic interventions [4-6]. 36 
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Fig.1. Trends in cancer mortality crude rates for children aged 0-14 years in England and Wales 74 
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